New drug-and-psychotherapy program for bipolar disorder in children

October 15, 2003

A psychiatrist at the University of Illinois at Chicago has devised a promising drug regimen for children with bipolar disorder.

In preliminary studies, the regimen, coupled with a psychotherapy program called RAINBOW, shows considerable success in alleviating the worst symptoms of the disease and enabling victims and families to cope.

"Bipolar disorder is often inappropriately treated," said Dr. Mani Pavuluri, director of the bipolar research program and the UIC pediatric mood disorders clinic, the only such clinic in the Chicago area.

"What's needed is a step-wise therapy that begins by stabilizing the child's mood and then moves on to address, each in turn, symptoms like attention deficit hyperactivity, residual depression and aggression that frequently accompany the illness," Pavuluri said. "Too often, children are treated first for attention deficit hyperactivity disorder (ADHD), resulting in a worsening of the mania."

According to Pavuluri, determining the correct medication for these children is crucial because drug therapies, such as antidepressants and stimulants, that are intended to alleviate symptoms can in fact trigger manic episodes, exacerbating the underlying condition.

Results of two studies by Pavuluri, one on her drug regimen and another on her RAINBOW program, will be presented Oct. 15 at a meeting of the American Academy of Child and Adolescent Psychiatry in Miami Beach, Fla.

Pavuluri formulated her treatment regime for the complex symptoms associated with pediatric bipolar disorder based on theoretical considerations and clinical findings in the literature that tested individual drugs.

"The aim is 'prescription hygiene,'" she said, "optimizing the number of drugs and their dosage so that only those that are effective are used and those that worsen symptoms are eliminated."

The regimen specifies four steps: 1) eliminating toxic drugs, 2) prescribing drugs that dampen the wild swings in mood, 3) aiming for a full recovery by adding a second mood stabilizer, if necessary, and 4) treating residual symptoms of inattention or aggression and sudden onset of other symptoms such as psychosis.

The preliminary trial compared outcomes for 64 children with bipolar disorder who underwent Pavuluri's drug regimen with outcomes for a group of children who received standard care. Ninety-four percent of the children in the test group improved, while none in the control group did.

Pavuluri's RAINBOW program, involving 12 hour-long psychotherapeutic sessions with both the children and their families, is based on cognitive behavioral therapy, which modifies undesirable emotions and behaviors by working on the thoughts that motivate them.

RAINBOW is an acronym to help families recall strategies for coping with the symptoms of the disease. Its letters stand for Routine; Affect (or emotional) regulation; "I can do it!" (promoting self-esteem); No negative thoughts; "Be a good friend!" or Balanced lifestyle, for parents; "Oh, how can we solve this problem?"; and Ways to get support.

With the changes in mood that occur with bipolar disorder, parents and siblings can be exhausted and strained, Pavuluri said. "One moment kids can be irritable, excitable, impulsive, intrusive, and loud; the next they are sullen, withdrawn and weepy," she said. "Families need coping and problem-solving strategies, which are incorporated into the RAINBOW framework."

In the preliminary study, 34 children who had been treated according to Pavuluri's drug regimen were enrolled in the RAINBOW program. They showed considerable reduction in symptoms, although Pavuluri cautions that the investigators were not blind to the treatment and consequently could have been biased.

Bipolar disorder is a devastating mood disturbance, characterized by cycling episodes of mania and depression, irritability and aggression, inflated self-esteem and grandiosity, decreased need for sleep, constant talking and activity and even psychosis. In children, it is associated with an alarming rate of suicide, failure in school, and engagement in high-risk behaviors such as sexual promiscuity and substance abuse. The disease is often misdiagnosed and, as a result, inappropriately treated.

"Advances in treating this serious disorder will come by combining a state-of-the-art medication regime with innovative and creative psychotherapy for the whole family," Pavuluri said.
-end-
For more information about UIC, visit www.uic.edu.

University of Illinois at Chicago

Related Bipolar Disorder Articles from Brightsurf:

Amygdala changes in male patients with schizophrenia and bipolar disorder
Researchers in Japan have revealed that DNA methylation occurs in the serotonin transporter gene that regulates neurotransmitter transmission in schizophrenia and bipolar patients.

Effect of high-deductible insurance use in bipolar disorder
A new study led by the Department of Population Medicine finds that individuals with bipolar disorder who switched to high-deductible health plans (HDHPs) experienced a moderate decrease in nonpsychiatrist mental health outpatient visits, but rates of psychiatrist visits, medication use, emergency department visits, and hospitalizations did not change.

Is bipolar disorder associated with increased risk of Parkinson's disease?
This study, called a systematic review and meta-analysis, combined the results of seven studies with 4.3 million participants to examine a potential association between bipolar disorder with a later diagnosis of Parkinson's disease of unknown cause.

Bipolar disorder may be linked to Parkinson's disease
People who have bipolar disorder may be more likely to later develop Parkinson's disease than people who do not have bipolar disorder, according at a study published in the May 22, 2019, online issue of Neurology®, the medical journal of the American Academy of Neurology.

Probiotics could help millions of patients suffering from bipolar disorder
About 3 million people in the US are diagnosed every year with bipolar disorder, a psychiatric condition characterized by dramatic shifts in mood from depression to mania.

Novel intervention for anxiety symptoms among people with Bipolar Disorder
Psychologists at Lancaster University have devised a novel psychological intervention to address Anxiety in Bipolar Disorder (AIBD).

Mutation links bipolar disorder to mitochondrial disease
Mutations in the gene ANT1 may confer a risk for bipolar disorder through a complex interplay between serotonin and mitochondrial signaling in the brain.

A new path into bipolar disorder comes to light
A new article authored by an international group of researchers reveals a novel potential drug target for bipolar disorder and offers new insights into the underlying biology of this lifelong and devastating mental illness.

After searching 12 years for bipolar disorder's cause, U-M team concludes it has many
Nearly 6 million Americans have bipolar disorder, and most have probably wondered why.

Simple EKG can determine whether patient has depression or bipolar disorder
A groundbreaking Loyola Medicine study suggests that a simple 15-minute electrocardiogram could help a physician determine whether a patient has major depression or bipolar disorder.

Read More: Bipolar Disorder News and Bipolar Disorder Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.